Log In Sign Up

SPYRAL HTN-OFF MED Pivotal Trial Post-Results Panel Discussion PART 2

  • 461 views
  • 30 Mar 2020
Like Comment

Share

Hypertension Renal Denervation (RDN)

WONDR MEDICAL

Follow

Wondr Medical is a medical publisher run by physicians for physicians bringing together medical educational resources from leading courses and conferences from all around the world.

Michael Böhm

Dr Böhm is Director of the Klinik für Innere Medizin III and Chief of Cardiology at the University of the Saarland in Homburg/Saar in Germany. He has been the principal investigator in several international multicenter studies.

Link to profile Follow

Felix Mahfoud

Dr Felix Mahfoud is associate professor and senior physician of Internal Medicine and Cardiology at Saarland University Hospital. He is involved in the design and execution of several pharmaceutical and interventional studies in hypertension treatment.

Link to profile Follow

Joachim Weil

Prof. Dr. Weil is Director of the Cardiovascular center at the Sana Clinic in Lübeck. His clinical focus is interventional therapy of coronary artery disease and arterial hypertension including renal denervation as well chronic heart failure

Link to profile Follow

David Kandzari

Dr. Kandzari is Director of Interventional Cardiology, Piedmont Heart Institute and Chief Scientific Officer, Piedmont Healthcare. He specializes in interventional cardiology, peripheral arterial disease and cardiovascular medicine.

Link to profile Follow

Justin Davies

Dr Justin Davies is a clinical academic and consultant interventional cardiologist at the National Heart and Lung Institute, Imperial College London. After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to work on the development of mathematical algorithms to aid understanding of large artery physiology...Read More

Link to profile Follow

Rasha Al-Lamee

Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK. Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is the lead author of the primary publication in The Lancet. At Imperial College, she is actively...Read More

Link to profile Follow

Related Videos

open video

WONDR MEDICAL

"HTN:RDN" The Definitive 4-Part Documentary Series on Hypertension & Renal...

open video

Simple Education

Essential skills: How to Determine the Cardiac Axis

open video

WONDR MEDICAL

HTN:RDN Episode 1. The History & The Hope

open video

Wondr Studios

HTN:RDN Episode 4. A Therapy for Today & Tomorrow

open video

Simple Education

Terminology – iFR, FFR, CFR, HSR what do all the abbreviations mean?

open video

WONDR MEDICAL

HTN:RDN Episode 3. Lesson Learned, Effectiveness Regained